Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

2-Fluoro-L-histidine, an Inhibitor of Enzyme Induction

DAVID C. KLEIN, KENNETH L. KIRK, JOAN L. WELLER, TAKAMI OKA, ANDREW PARFITT and IDA S. OWENS
Molecular Pharmacology September 1976, 12 (5) 720-730;
DAVID C. KLEIN
Section on Physiological Controls, Laboratory of Biomedical Sciences, and Section on Developmental Pharmacology, Neonatal and Pediatric Medicine Branch, National Institute of Child Health and Human Development; and Section on Biochemical Mechanisms, Laboratory of Chemistry, and Section on Intermediary Metabolism, Laboratory of Biochemistry and Metabolism, National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KENNETH L. KIRK
Section on Physiological Controls, Laboratory of Biomedical Sciences, and Section on Developmental Pharmacology, Neonatal and Pediatric Medicine Branch, National Institute of Child Health and Human Development; and Section on Biochemical Mechanisms, Laboratory of Chemistry, and Section on Intermediary Metabolism, Laboratory of Biochemistry and Metabolism, National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOAN L. WELLER
Section on Physiological Controls, Laboratory of Biomedical Sciences, and Section on Developmental Pharmacology, Neonatal and Pediatric Medicine Branch, National Institute of Child Health and Human Development; and Section on Biochemical Mechanisms, Laboratory of Chemistry, and Section on Intermediary Metabolism, Laboratory of Biochemistry and Metabolism, National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKAMI OKA
Section on Physiological Controls, Laboratory of Biomedical Sciences, and Section on Developmental Pharmacology, Neonatal and Pediatric Medicine Branch, National Institute of Child Health and Human Development; and Section on Biochemical Mechanisms, Laboratory of Chemistry, and Section on Intermediary Metabolism, Laboratory of Biochemistry and Metabolism, National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANDREW PARFITT
Section on Physiological Controls, Laboratory of Biomedical Sciences, and Section on Developmental Pharmacology, Neonatal and Pediatric Medicine Branch, National Institute of Child Health and Human Development; and Section on Biochemical Mechanisms, Laboratory of Chemistry, and Section on Intermediary Metabolism, Laboratory of Biochemistry and Metabolism, National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
IDA S. OWENS
Section on Physiological Controls, Laboratory of Biomedical Sciences, and Section on Developmental Pharmacology, Neonatal and Pediatric Medicine Branch, National Institute of Child Health and Human Development; and Section on Biochemical Mechanisms, Laboratory of Chemistry, and Section on Intermediary Metabolism, Laboratory of Biochemistry and Metabolism, National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 12 no. 5 720-730
PubMed 
11408

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Published online September 1, 1976.

Copyright & Usage 
Copyright © 1976 by Academic Press, Inc.

Author Information

  1. DAVID C. KLEIN,
  2. KENNETH L. KIRK,
  3. JOAN L. WELLER,
  4. TAKAMI OKA,
  5. ANDREW PARFITT, and
  6. IDA S. OWENS
  1. Section on Physiological Controls, Laboratory of Biomedical Sciences, and Section on Developmental Pharmacology, Neonatal and Pediatric Medicine Branch, National Institute of Child Health and Human Development; and Section on Biochemical Mechanisms, Laboratory of Chemistry, and Section on Intermediary Metabolism, Laboratory of Biochemistry and Metabolism, National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20014

Statistics from Altmetric.com

Article usage

Article usage: September 2005 to May 2023

AbstractFullPdf
Sep 2005100
Dec 2005100
Mar 2006200
Apr 2006200
May 2006101
Jun 2006800
Aug 2006101
Sep 2006200
Oct 2006401
Nov 2006200
Dec 2006400
Jan 2007300
Feb 2007300
Mar 2007303
Apr 2007002
May 2007301
Jun 2007200
Jul 2007101
Aug 2007400
Sep 2007100
Oct 2007200
Nov 2007200
Dec 2007100
Jan 2008100
Feb 2008001
Mar 2008200
Apr 2008400
May 2008201
Jun 2008400
Jul 2008201
Aug 2008402
Sep 2008700
Oct 2008502
Dec 2008201
Jan 2009701
Feb 2009600
Mar 2009201
Apr 2009102
May 2009301
Jun 2009203
Jul 2009102
Aug 2009701
Sep 2009502
Oct 2009404
Nov 2009702
Dec 2009200
Jan 2010404
Feb 2010500
Mar 2010701
Apr 2010200
May 2010400
Jun 2010300
Jul 2010400
Aug 2010400
Sep 2010201
Oct 2010105
Nov 2010100
Dec 2010501
Jan 2011900
Feb 2011700
Mar 2011303
Apr 2011501
May 2011300
Jun 2011200
Jul 20111201
Aug 2011801
Sep 20111400
Oct 2011701
Nov 20113100
Dec 20111202
Jan 20121000
Feb 20121801
Mar 20121302
Apr 20121300
May 20121102
Jun 20121000
Jul 20121501
Aug 20121400
Sep 2012700
Oct 20121001
Nov 20121500
Dec 20121601
Jan 20132200
Feb 2013700
Mar 20133500
Apr 20132200
May 20132601
Jun 2013403
Jul 2013300
Aug 2013701
Sep 20131000
Oct 2013700
Nov 2013500
Dec 2013302
Jan 2014500
Feb 20141122
Mar 2014712
Apr 2014600
May 2014300
Oct 2014601
Nov 2014400
Dec 2014400
Feb 2015400
Mar 20151603
Apr 2015100
May 2015500
Jun 2015401
Jul 2015502
Aug 2015200
Sep 2015502
Oct 20151000
Nov 2015800
Dec 2015400
Jan 2016500
Feb 20161100
Mar 20161302
Apr 2016501
May 2016100
Jun 2016601
Jul 2016300
Aug 2016602
Sep 2016700
Oct 2016900
Nov 20161101
Dec 2016500
Jan 2017600
Feb 2017900
Mar 20171000
Apr 20171401
May 20171400
Jun 20171401
Jul 20172301
Aug 20171300
Sep 20172800
Oct 20171300
Nov 20172203
Dec 20172801
Jan 20181600
Feb 2018900
Mar 20181200
Apr 20183601
May 20181200
Jun 20181901
Jul 2018901
Aug 20181300
Sep 2018300
Oct 2018500
Nov 2018400
Dec 20181100
Jan 2019501
Feb 20191200
Mar 2019700
Apr 20191300
May 20191000
Jun 2019602
Jul 2019400
Aug 2019300
Sep 2019500
Oct 2019500
Nov 2019800
Dec 2019800
Jan 2020400
Feb 20201000
Mar 2020501
Apr 2020500
May 2020400
Jun 2020100
Jul 2020200
Sep 2020200
Nov 2020400
Dec 2020300
Jan 20211002
Feb 2021600
Mar 2021600
Apr 20215600
May 20217300
Jun 2021100
Jul 2021900
Aug 2021200
Sep 2021400
Oct 20212500
Nov 20211501
Dec 2021700
Jan 20221200
Feb 2022200
Mar 2022500
Apr 2022600
May 2022600
Jun 20221000
Jul 20221400
Aug 20221101
Sep 2022600
Oct 2022602
Nov 2022500
Dec 2022300
Jan 2023200
Feb 2023200
Mar 2023501
Apr 2023500
May 2023600

PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 12, Issue 5
1 Sep 1976
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
2-Fluoro-L-histidine, an Inhibitor of Enzyme Induction
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

2-Fluoro-L-histidine, an Inhibitor of Enzyme Induction

DAVID C. KLEIN, KENNETH L. KIRK, JOAN L. WELLER, TAKAMI OKA, ANDREW PARFITT and IDA S. OWENS
Molecular Pharmacology September 1, 1976, 12 (5) 720-730;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

2-Fluoro-L-histidine, an Inhibitor of Enzyme Induction

DAVID C. KLEIN, KENNETH L. KIRK, JOAN L. WELLER, TAKAMI OKA, ANDREW PARFITT and IDA S. OWENS
Molecular Pharmacology September 1, 1976, 12 (5) 720-730;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cysteine151 in Keap1 Drives CDDO-Me Pharmacodynamic Action
  • Allosteric Modulation of Metabotropic Glutamate Receptor 1
  • Mechanism of Selective Action of Paraherquamide A
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics